Short answer · Medically reviewed summary · Last updated: 2026-05-08
Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder primarily referred to by its full name or the abbreviation CFC syndrome. While it does not have a wide array of formal synonyms, it is occasionally historically grouped within the "RASopathy" family of disorders, and patients may encounter older clinical references that describe it by its primary symptom triad involving cardiac, facial, and cutaneous characteristics. What are the official clinical names for Cardiofaciocutaneous syndrome? In medical literature and international databases, the condition is officially recognized as Cardiofaciocutaneous syndrome.
Cardiofaciocutaneous / Cfc Syndrome synonyms
Other names for Cardiofaciocutaneous / Cfc Syndrome: synonyms, acronyms and related terms used by doctors and patients.
Cardiofaciocutaneous (CFC) syndrome is a rare genetic disorder primarily referred to by its full name or the abbreviation CFC syndrome. While it does not have a wide array of formal synonyms, it is occasionally historically grouped within the "RASopathy" family of disorders, and patients may encounter older clinical references that describe it by its primary symptom triad involving cardiac, facial, and cutaneous characteristics.
What are the official clinical names for Cardiofaciocutaneous syndrome?
In medical literature and international databases, the condition is officially recognized as Cardiofaciocutaneous syndrome. Medical professionals and geneticists consistently use this name because it accurately describes the three hallmark systems affected: the heart (cardio), the facial features (facio), and the skin (cutaneous). In the Online Mendelian Inheritance in Man (OMIM) database, it is cataloged under the entry #115150. Orphanet classifies the condition as ORPHA:158, ensuring consistency across global clinical trials and research initiatives.
Why does Cardiofaciocutaneous syndrome have multiple descriptors?
Historically, Cardiofaciocutaneous syndrome was sometimes confused with other disorders in the RASopathy spectrum, such as Costello syndrome or Noonan syndrome, due to overlapping physical characteristics. As genetic testing has advanced, clinicians have clarified that Cardiofaciocutaneous syndrome is distinct, typically caused by de novo mutations in the BRAF, MAP2K1, or MAP2K2 genes. Because the condition is defined by its genetic etiology rather than just its appearance, the medical community has moved away from descriptive or historical labels in favor of the standardized name.
Commonly used terms and nomenclature
When reviewing medical records or searching for Cardiofaciocutaneous syndrome, you may encounter the following terms:
- CFC syndrome: The most common abbreviation used in clinical notes and research papers.
- RASopathy: A broader category of genetic syndromes that includes Cardiofaciocutaneous syndrome, often used when discussing shared molecular pathways.
- CFC: A shorthand identifier frequently used in patient support networks and international research registries.
Next steps
- Consult a clinical geneticist to confirm the specific gene mutation associated with your diagnosis of Cardiofaciocutaneous syndrome.
- Join the 36 community members on DiseaseMaps.org to share experiences and find peer support.
- Visit the CFC International foundation website for specialized resources and clinical updates.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider.
References
- Orphanet: Cardiofaciocutaneous syndrome (ORPHA:158)
- NIH GARD: Cardiofaciocutaneous syndrome (GARD:10067)
- OMIM: Cardiofaciocutaneous syndrome (OMIM #115150)
- CFC International: Official Patient Advocacy and Support Organization
